Dermatan sulfate as a potential therapeutic agent
- 31 May 1995
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 26 (3) , 443-451
- https://doi.org/10.1016/0306-3623(94)00231-b
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: Importance of heparin cofactor IIThrombosis Research, 1994
- Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukaemia: A randomised, heparin-controlled pilot studyThrombosis Research, 1994
- Glycosaminoglycans and the regulation of blood coagulationBiochemical Journal, 1993
- Glycosaminoglycans in Prophylaxis Against Venous ThromboembolismPublished by Springer Nature ,1992
- Pharmacokinetics of Heparin and of Dermatan Sulfate: Clinical ImplicationsPublished by Springer Nature ,1992
- An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.Journal of Clinical Investigation, 1992
- Structure and properties of dermatan sulphate proteoglycansBiochemical Society Transactions, 1991
- Low-Molecular-Weight Heparins and Heparinoids and their Use in Acute or Progressing Ischemic StrokeClinical Neuropharmacology, 1990
- Transforming growth factor-β regulates production of proteoglycans by mesangial cellsKidney International, 1990
- Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor IIBiochemical and Biophysical Research Communications, 1983